According to the current knowledge, due to the overlapping features between endometrial stromal and smooth muscle differentiation, sarcomas with the KAT6B/A::KANSL1 fusion cannot be diagnosed based only on the morphological and immunohistochemical features, and molecular testing is needed. Here, KANSL1 is linked to sarcoma.